ACE2 and obesity disorder: Considering that the severity of COVID-19 is highly associated with an age over 70 years (except for obesity) assessing the role of age on ACE2 expression in patients with comorbidities in extensive retrospective epidemiological studies would provide a broader picture of risk factors and accurately inform on the potential consequences of modulating ACE2.